Review Article

Reproductive Factors but Not Hormonal Factors Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis

Table 2

Summary results for the association between hormonal and reproductive factors and thyroid cancer risk.

ComparisonsaRRb95% CI value Tests for heterogeneity
(%)

All
 Oral contraceptive0.940.85–1.040.21536.00.095
 Hormone replacement therapy1.040.91–1.190.52700.520
 Age at menarche 1.080.97–1.190.14200.486
 Parity 1.100.94–1.280.23461.2<0.001
 Age at first birth 1.070.95–2.200.25514.80.281
 Menopausal status 0.960.79–1.180.7274.90.394
 Age at menopause1.241.00–1.530.04926.40.201
 Duration of breast feeding0.840.65–1.080.17838.30.150
 Breast feeding 0.840.69–1.020.0804.90.368
Cohort studies
 Oral contraceptive0.960.86–1.070.44839.50.104
 Hormone replacement therapy1.050.91–1.200.51300.439
 Age at menarche 1.010.90–1.140.80816.10.299
 Parity 1.000.78–1.280.99370.6<0.001
 Age at first birth 1.040.92–1.180.53000.571
 Menopausal status 0.900.71–1.150.41826.60.252
 Age at menopause 1.31.04–1.630.0222.50.400
 Duration of breast feeding 0.700.51–0.950.02100.661
 Breast feeding 0.820.66–1.020.07800.442
PCC
 Oral contraceptive 0.890.73–1.080.24041.00.166
 Hormone replacement therapy 1.010.68–1.500.9626.00.363
 Age at menarche 1.281.04–1.570.96000.937
 Parity 1.000.93–1.070.96021.60.258
 Age at first birth 1.350.97–1.880.07242.30.123
 Menopausal status 1.100.78–1.570.57700.481
 Age at menopause 0.820.43–1.560.55444.00.147
 Duration of breast feeding 1.240.80–1.930.33228.20.248
 Breast feeding 0.920.60–1.410.69957.60.125
HCC
 Parity 2.301.31–4.040.00400.787

aRR: relative risk; b95% CI: 95% confidence interval; cP: the value of for pooled analysis; dP: the value of for heterogeneity analysis.